Spinal Simplicity, LLC
Records under this name other than the patents Spinal Simplicity, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 78 patents it holds.
Back to Spinal Simplicity, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,737,792 | Spinal Implant with Ball and Socket Joint Having Multiple Radius Tear Shaped Geometry Formerly held In force · High confidence | In force | High confidence | |
| US 8,119,599 | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity Term ended Term ended Apr 1, 2025 · From the USPTO record | Term ended | Term ended Apr 1, 2025 | From the USPTO record |
| US 7,435,722 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability Term ended Term ended Jan 19, 2025 · From the USPTO record | Term ended | Term ended Jan 19, 2025 | From the USPTO record |
| US 9,101,602 | Use of Non-Toxic Crosslinking Reagents to Improve Fatigue Resistance and Reduce Mechanical Degradation of Intervertebral Disc and Other Collagenous Tissues Term ended Ended no later than Mar 16, 2024 · Medium confidence | Term ended | Ended no later than Mar 16, 2024 | Medium confidence |
| US 8,450,276 | Non-Toxic Crosslinking Reagents to Resist Curve Progression in Scoliosis and Increase Disc Permeability Term ended Ended no later than Aug 1, 2023 · Low confidence | Term ended | Ended no later than Aug 1, 2023 | Low confidence |
| US 8,211,938 | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity Term ended Term ended May 7, 2023 · From the USPTO record | Term ended | Term ended May 7, 2023 | From the USPTO record |
| US 9,192,507 | Tissue crosslinking for treatment of snoring and obstructive sleep apnea Term ended Term ended Jan 6, 2023 · From the USPTO record | Term ended | Term ended Jan 6, 2023 | From the USPTO record |
| US 10,980,771 | Crosslinker enhanced repair of connective tissues Term ended Term ended Dec 18, 2022 · From the USPTO record | Term ended | Term ended Dec 18, 2022 | From the USPTO record |
| US 8,022,101 | Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing Term ended Term ended Oct 23, 2022 · From the USPTO record | Term ended | Term ended Oct 23, 2022 | From the USPTO record |
| US 9,918,870 | Tissue crosslinking for treatment of snoring and obstructive sleep apnea Term ended Term ended Oct 7, 2022 · From the USPTO record | Term ended | Term ended Oct 7, 2022 | From the USPTO record |